Drug manufacturer United Therapeutics on Monday told covered entities what they must do to keep getting 340B pricing from the company on its drugs when dispensed by the entities’ retail pharmacy partners.

News Alert: United Therapeutics Unveils 340B Contract Pharmacy Claims Submission Requirement

Drug manufacturer United Therapeutics on Monday launched phase two of its restrictions on 340B contract pharmacy, telling covered entities what they must do to keep getting 340B pricing from the company on its drugs when dispensed by the entities’ retail pharmacy partners.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »